Who We Are
Pharmaceutical rigor, applied to hemp
CCT Sciences is a Florida-based research and development company founded in 2020. Our scientific team brings decades of pharmaceutical experience developing processes for Fortune 100 companies — and we apply that same rigor to hemp-derived cannabinoids. We develop, patent, and license the technology behind compliant cannabinoid products, with chain-of-custody documentation from biomass to finished good.

Covered products include, but are not limited to, vapes, gummies, and beverages.
Nano Encapsulation
Water-soluble. Fast-acting. Patent-pending.
Our patent-pending, water-soluble nano encapsulation delivers sub-100nm particle size, faster onset, and dramatically increased absorption for beverages and fast-acting edibles. Produced with U.S.-sourced ingredients — for a single cannabinoid or custom blends.

Frequently Asked Questions
What patents does CCT Sciences hold?
Four granted U.S. patents: US 11,292,779 B1 (Delta-8 THC production), US 11,753,390 B2 (Delta-8 THC consumer products), and US 12,029,718 B2 and US 12,458,620 B2 (Delta-9 THC production and consumer products).
​​
What products do the patents cover?
The production of hemp-derived Delta-8 and Delta-9 THC and consumer products made from them, including, but not limited to, vapes, gummies, and beverages.
​
What is CCT's nano encapsulation?
A patent-pending, water-soluble formulation with sub-100nm particle size, designed for fast-acting beverages and edibles using a single cannabinoid or custom blends.
​
How do I license CCT's technology?
Contact us through the form on our Contact page or at info@cctsciences.com to discuss product fit and licensing.
​
Where is CCT Sciences located?
200 1st Avenue North, STE 206, St. Petersburg, Florida 33701.





